DexCom reported third quarter 2026 sales of US$1.34b with stable basic EPS from continuing operations, raised full year revenue guidance, and announced a US$1b share repurchase program running through...
Source LinkDexCom reported third quarter 2026 sales of US$1.34b with stable basic EPS from continuing operations, raised full year revenue guidance, and announced a US$1b share repurchase program running through...
Source Link
Comments